SEC Filings | Celldex Therapeutics

Form	Description	Filing date	View
8-K	Report of unscheduled material events or corporate event	Apr 3, 2012	View HTML 0001104659-12-023622.pdf 0001104659-12-023622.rtf 0001104659-12-023622.xls
SC 13G/A	An amendment to the SC 13G filing	Mar 12, 2012	View HTML 0001086364-12-002222.pdf 0001086364-12-002222.rtf
10-K	Annual report which provides a comprehensive overview of the company for the past year	Mar 8, 2012	View HTML 0001047469-12-002276.pdf 0001047469-12-002276.rtf 0001047469-12-002276.xls EX-101.INS - EX-101.INS
8-K	Report of unscheduled material events or corporate event	Mar 7, 2012	View HTML 0001104659-12-016044.pdf 0001104659-12-016044.rtf 0001104659-12-016044.xls
8-K	Report of unscheduled material events or corporate event	Feb 24, 2012	View HTML 0001104659-12-012515.pdf 0001104659-12-012515.rtf 0001104659-12-012515.xls
424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Feb 24, 2012	View HTML 0001047469-12-001468.pdf 0001047469-12-001468.rtf 0001047469-12-001468.xls
8-K	Report of unscheduled material events or corporate event	Feb 23, 2012	View HTML 0001104659-12-012137.pdf 0001104659-12-012137.rtf 0001104659-12-012137.xls
424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Feb 23, 2012	View HTML 0001047469-12-001366.pdf 0001047469-12-001366.rtf 0001047469-12-001366.xls
SC 13G/A	An amendment to the SC 13G filing	Feb 13, 2012	View HTML 0001086364-12-001516.pdf 0001086364-12-001516.rtf
10-Q	Quarterly report which provides a continuing view of a company's financial position	Nov 3, 2011	View HTML 0001104659-11-060466.pdf 0001104659-11-060466.rtf 0001104659-11-060466.xls EX-101.INS - XBRL INSTANCE DOCUMENT

Data provided by Kaleidoscope.